PT  - JOURNAL ARTICLE
AU  - Matthew F. Covington
AU  - Ephraim E. Parent
AU  - Elizabeth H. Dibble
AU  - Gaiane M. Rauch
AU  - Amy M. Fowler
TI  - Advances and Future Directions in Molecular Breast Imaging
AID  - 10.2967/jnumed.121.261988
DP  - 2022 Jan 01
TA  - Journal of Nuclear Medicine
PG  - 17--21
VI  - 63
IP  - 1
4099  - http://jnm.snmjournals.org/content/63/1/17.short
4100  - http://jnm.snmjournals.org/content/63/1/17.full
SO  - J Nucl Med2022 Jan 01; 63
AB  - Molecular breast imaging (MBI) using 99mTc-sestamibi has advanced rapidly over the past decade. Technical advances allow lower-dose, higher-resolution imaging and biopsy capability. MBI can be used for supplemental breast cancer screening with mammography for women with dense breasts, as well as to assess neoadjuvant therapy response, evaluate disease extent, and predict breast cancer risk. This article highlights the current state of the art and future directions in MBI.